Search
for
Sort by
Research 331–360 of 1000+
- Immunopathogenesis of Primary Cicatricial Alopecia
- Gonads
- Polycystic Ovary Syndrome in Adolescents
- The in vitro plasticity of hair follicle dermal and mesenchymal stem cells
- Insulin Resistance and Polycystic Ovary Syndrome
- 13. Wound Healing & Hair
- 5. HIV, Fungal and Infectious Diseases
- 4. Bullous/Mucous Membrane
- Poster session
- National scientific medical meeting 1996 abstracts
- LITERATURE REVIEW
- Obesity and the skin: Skin physiology and skin manifestations of obesity
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
- The diagnosis and treatment of iron deficiency and its potential relationship to hair loss
- Anthracycline analogs The past, present, and future
- K channel therapeutics at the bedside
- Extracellular vesicles derived from MSCs activates dermal papilla cell in vitro and promotes hair follicle conversion from telogen to anagen in mice
- Multidisciplinary treatment of obesity with a protein-sparing modified fast: results in 668 outpatients.
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- 17-Hydroxyprogesterone Responses to Gonadotropin-Releasing Hormone Disclose Distinct Phenotypes of Functional Ovarian Hyperandrogenism and Polycystic Ovary Syndrome
- TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia
- The Clinical Presentation of Systemic Lupus Erythematosus
- Potassium channel openers: therapeutic potential in cardiology and medicine
- Hirsutism in the Adolescent Female
- Drug eruptions in dermatology
- Role of umbilical cord mesenchymal stromal cells in skin rejuvenation
- Polymeric micelle mediated follicular delivery of spironolactone: Targeting the mineralocorticoid receptor to prevent glucocorticoid-induced activation and delayed cutaneous wound healing
- Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective
- Rituximab for Bone Lymphoma
- Syphilis: today